Cancer Doctors Want Pay Based On Drug Prices Higher Than Medicare Negotiates

Medicare payments to cancer doctors fall with lower drug prices, and the Community Oncology Alliance tried to get Congress to base their pay on what drugs would cost without Medicare price negotiation, but they were ignored. The cancer doctor group continues to lobby Congress for changes. Democrats passed drug pricing legislation over the summer that directs Medicare to negotiate prices after drugs and biologics have been on the market for several years, and the law makes drug companies pay back...
Article Type: 
Site Name: 
InsideHealthPolicy.com
IDP Issue: 
Inside Drug Pricing - 10/10/2022
IDP Volume: 
Vol. 5, No. 41
Author: 


WTO Members Develop TRIPS Schedule As Expansion Deadline Looms

Editor's Note: This story has been updated to better reflect the U.S.' brief remarks. World Trade Organization members will meet at least three times in the coming months to discuss expanding their recent decision to broaden intellectual property flexibilities for COVID-19 vaccines to include tests and treatments, a proposal they must accept -- or not -- by mid-December. The 12th ministerial conference decision to broaden flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights to facilitate...
Article Type: 
Tags: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 10/07/2022
FDA Volume: 
Vol. 28, No. 40
CMS Issue: 
Inside CMS - 10/06/2022
CMS Volume: 
Vol. 25, No. 40
Author: 

HHS Collects 1557 Comments As Lobbyists Turn Focus On Year-End Package

Stakeholders are commenting on the Biden administration’s proposed rule on the Affordable Care Act’s 1557 non-discrimination provision, while CMS and FDA lobbyists regroup following Congress’ passage last week of a stop-gap funding bill to now push for funding and policy riders to be wrapped into a year-end omnibus spending package. The White House Office of Management and Budget, meanwhile, is working through the final pay rules for Medicare providers for 2023. Comments were due Monday (Oct. 3) on the Biden...
Overline: 
Health Insider
Article Type: 
Site Name: 
InsideHealthPolicy.com
Author: 
Secondary Author(s): 

HHS Touts Start Of Biosimilars Measure, But Not Rebates, Which Save Much More

On Oct. 1, a drug pricing measure took effect that increases Medicare pay to doctors who prescribe biosimilars, and Biden administration officials touted that measure on Monday as part of the administration “moving full-speed ahead” on drug price controls, but they didn’t mention Part D inflation rebates, which also took effect on Oct. 1, that save the government and consumers a lot more money than the biosimilar measure. The Inflation Reduction Act increases the add-on payment for biosimilars, which are...
Article Type: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 10/07/2022
FDA Volume: 
Vol. 28, No. 40
CMS Issue: 
Inside CMS - 10/06/2022
CMS Volume: 
Vol. 25, No. 40
Author: 

MedPAC Members Worry Telehealth Additive, Ponder How To Extend Care But Cut Costs

Medicare payment advisers raised concerns that telehealth services are additive to in-person care and could drive up Medicare costs if permanent flexibilities are enacted, but they didn’t cite any specific research to back up their concerns. At a Medicare Payment Advisory Commission meeting Thursday (Sept. 29), some commissioners also noted that patients have been satisfied with their use of telehealth during the pandemic, and they suggested MedPAC look at how telehealth could be used to extend care but not increase...
Article Type: 
Site Name: 
InsideHealthPolicy.com
Author: 
Topics: 

High Telehealth Utilization Could Cancel Out Cost Savings, CBO Says

The increased utilization of health care services enabled by widespread adoption of telehealth could cancel out some of the cost savings that competition from virtual care could bring to the health care system moving forward, the Congressional Budget Office says in a policy paper laying out potential ways to reduce commercial insurers’ costs. Titled “Policy Approaches to Reduce What Commercial Insurers Pay for Hospitals’ and Physicians’ Services,” the report released Thursday (Sept. 29) details policies that could drive down costs...
Article Type: 
Tags: 
Site Name: 
InsideHealthPolicy.com
CMS Issue: 
Inside CMS - 10/06/2022
CMS Volume: 
Vol. 25, No. 40
HEA Issue: 
Health Exchange Alert Weekly Report - 10/05/2022
HEA Volume: 
Vol. 10, No. 40
Author: 

Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.